ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Publisher Receives Six Figures Settlement In Copyright Case

May 11, 1990

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

$1 Million Gift to Duke Funds Urologic Research Center.

November 24, 2000

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977